Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies

Journal of the American Academy of Dermatology

Volumn 56, Issue 1, 2007, Pages 153-159

  Cummins, Deborah L ^a   Mimouni, Daniel ^b   Tzu, Julia ^d   Owens, Nicole ^c   Anhalt, Grant J ^a   Meyerle, Jon H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; PREDNISONE; RITUXIMAB;

ADULT; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CHEEK MUCOSA; CLINICAL FEATURE; CYTOTOXIC T LYMPHOCYTE; ESOPHAGUS BIOPSY; EYE EXAMINATION; FEMALE; HISTOLOGY; HUMAN; LICHENOID; LICHENOID ERUPTION; LICHENOID PARANEOPLASTIC PEMPHIGUS; LUNG FUNCTION TEST; MALE; MOUTH DISEASE; MUCOSA INFLAMMATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DISEASE;

AGED; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOANTIBODIES; B-LYMPHOCYTES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESOPHAGEAL DISEASES; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LICHENOID ERUPTIONS; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; LYMPHOMA, SMALL CLEAVED-CELL, FOLLICULAR; LYMPHOMA, SMALL-CELL; MALE; MIDDLE AGED; MUCOSITIS; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; PREDNISONE; RECURRENCE; T-LYMPHOCYTES; VIDARABINE; VINCRISTINE;

EID: 33845864766     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.06.007     Document Type: Article

References (21)

1. Nousari H.C., Deterding R., Wojtczack H., Aho S., Uitto J., Hashimoto T., et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 340 (1999) 1406-1410
2. Anhalt G.J., Kim S., Stanley J.R., Korman N.J., Jabs D.A., Kory M., et al. Paraneoplastic pemphigus-an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323 (1999) 1729-1735
3. Bowen G.M., Peters N.T., Fivenson D.P., Su L.D., Nousari H.C., Anhalt G.J., et al. Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading?. Arch Dermatol 136 (2000) 652-656
4. Reich K., Brinck U., Letschert M., Blaschke V., Dames K., Braess J., et al. Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus. Br J Dermatol 141 (1999) 739-746
5. Marzano A.V., Grammatica A., Cozzani E., Terracina M., and Berti E. Paraneoplastic pemphigus. A report of two cases associated with chronic B-cell lymphocytic leukaemia. Br J Dermatol 145 (2001) 127-131
6. van der Waal R.I.F., Pas H.H., Anhalt G.J., Schulten E.A.J.M., Jonkman M.F., and Nieboer C. Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue. Oral Oncol 34 (1998) 567-570
7. Inaoki M., Kodera M., Fujimoto A., Nousari H.C., Anhalt G.J., and Takehara K. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies. Br J Dermatol 144 (2001) 610-613
8. Hoffman M.A., Qiao X., and Anhalt G.J. CD8+ T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman's disease. N Engl J Med 349 (2003) 407-408
9. Jordon R.E., Triftshauser C.T., and Schroeter A.L. Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol 103 (1971) 486-491
10. Anhalt G.J., Kim S.C., Stanley J.R., Korman N.J., Jabs D.A., Kory M., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323 (1990) 1729-1735
11. Stanley J.R., Koulu L., and Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest 74 (1984) 313-320
12. Nguyen V.T., Ndoye A., Bassler K.D., Shultz L.D., Shields M.C., Ruben B.S., et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. ArchDermatol 137 (2001) 193-206
13. Higashida J., Wun T., Schmidt S., Naguwa S.M., and Tuscano J.M. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment. J Rheumatol 32 (2005) 2109-2115
14. Cooper N., Stasi R., Cunningham-Rundles S., Feuerstein M.A., Leonard J.P., Amadori S., et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 125 (2004) 232-239
15. Anolik J.H., Barnard J., Cappione A., Pugh-Bernard A.E., Felgar R.E., Looney R.J., et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 50 (2004) 3580-3590
16. Morrison L.H. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab). J Am Acad Dermatol 51 (2004) 817-819
17. Schmidt E., Herzog S., Bröcker E.B., Zillikens D., and Goebeler M. Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab. Br J Dermatol 153 (2005) 449-451
18. Nousari H.C., Kimyai-Asadi A., and Anhalt G.J. Elevated serum levels of interleukin-6 in paraneoplastic pemphigus. J Invest Dermatol 112 (1999) 396-398
19. Majeski E.I., Paintlia M.K., Lopez A.D., Harley R.A., London S.D., and London L. Respiratory retrovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes. Am J Pathol 163 (2003) 1467-1479
20. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., and Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 4 (1998) 1321-1324
21. Hohwy T., Bang K., Steniche T., Peterslund N.A., and d'Amore F. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia. Eur J Haematol 73 (2004) 206-209